Biosciences

Covid vaccine patent waivers – the opinion of our vaccine IP specialist

May 6, 2021 | Tags: Octrooien , Biosciences , IP Insight

Medical inventions – a European perspective

Jan 19, 2021 | Tags: Octrooien , Biosciences , IP Insight

No SPCs for new therapeutic applications of old drugs – CJEU overturns Neurim

Jul 16, 2020 | Tags: Octrooien , Biosciences , IP Insight

“No Patents On Peppers”… or any plants or animals exclusively obtained by means of an essentially biological process

May 27, 2020 | Tags: Octrooien , Biosciences , Food and drink , IP Insight

Mobile apps at the forefront of the Covid-19 fight

May 13, 2020 | Tags: Octrooien , Merken , Biosciences , Modellen , Software

Institutions inject flexibility into IP relevant to COVID-19 vaccines and medicines

Apr 22, 2020 | Tags: Octrooien , Biosciences

News Flash Update: EPO and EUIPO Deadlines extended

Mar 16, 2020 | Tags: Octrooien , Merken , Biosciences , Modellen

Vitamins, Nutraceuticals and Trade Marks

Aug 12, 2019 | Tags: Merken , Biosciences , Food and drink

UK Supreme Court approves ‘Skinny Labelling’ (pdf)

Dec 18, 2018 | Tags: Octrooien , Biosciences , IP Insight

The UK Supreme Court re-vitalises patent infringement by equivalents (pdf)

Jul 13, 2017 | Tags: Octrooien , Biosciences

Is it obvious to try? December 2015 (pdf)

Dec 3, 2015 | Tags: Octrooien , Biosciences

Second Medical Use Claims - a painful odyssey (pdf)

May 6, 2015 | Tags: Octrooien , Biosciences

Biosciences and Pharma Group Newsletter - May 2013 (pdf)

May 1, 2013 | Tags: Octrooien , Biosciences